0001732863-18-000001.txt : 20180228 0001732863-18-000001.hdr.sgml : 20180228 20180228095437 ACCESSION NUMBER: 0001732863-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 EFFECTIVENESS DATE: 20180228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MDI Therapeutics, Inc. CENTRAL INDEX KEY: 0001732863 IRS NUMBER: 811591048 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-306601 FILM NUMBER: 18648472 BUSINESS ADDRESS: STREET 1: 46430 STREET 2: PEARY COURT CITY: NOVI STATE: MI ZIP: 48377 BUSINESS PHONE: 2693700775 MAIL ADDRESS: STREET 1: 46430 STREET 2: PEARY COURT CITY: NOVI STATE: MI ZIP: 48377 D 1 primary_doc.xml X0708 D LIVE 0001732863 MDI Therapeutics, Inc. 46430 PEARY COURT NOVI MI MICHIGAN 48377 2693700775 MICHIGAN Medigenixbio, Inc. None Corporation true 2015 Stephen Benoit 46430 Peary Court Novi MI MICHIGAN 48377 Executive Officer Director Duane Day 46430 Peary Court Novi MI MICHIGAN 48377 Executive Officer Director Daniel Lawrence, Ph.D. 46430 Peary Court Novi MI MICHIGAN 48377 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false true false true Convertible Note/SAFE (simple agreement for future equity) false 250000 1550000 0 1550000 $1,250,000 of convertible notes and up to $300,000 of simple agreement for equity (SAFE) false 0 0 0 0 false MDI Therapeutics, Inc. Stephen Benoit Stephen Benoit CEO and President 2018-02-20